Statistics for The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.
Total visits
| views | |
|---|---|
| The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy. | 86 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.pdf | 122 |
Top country views
| views | |
|---|---|
| Germany | 6 |
| United States | 3 |
| United Kingdom | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 1 |
| Brooklyn | 1 |
| Changi | 1 |
| Houston | 1 |